WO2001004828A1 - Detection automatique d'objets dans un echantillon biologique - Google Patents
Detection automatique d'objets dans un echantillon biologique Download PDFInfo
- Publication number
- WO2001004828A1 WO2001004828A1 PCT/US2000/019046 US0019046W WO0104828A1 WO 2001004828 A1 WO2001004828 A1 WO 2001004828A1 US 0019046 W US0019046 W US 0019046W WO 0104828 A1 WO0104828 A1 WO 0104828A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- interest
- slide
- image
- candidate object
- stage
- Prior art date
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 18
- 239000012472 biological sample Substances 0.000 title description 2
- 238000000034 method Methods 0.000 claims abstract description 143
- 230000002062 proliferating effect Effects 0.000 claims abstract description 12
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 10
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 9
- 238000012545 processing Methods 0.000 claims description 38
- 206010028980 Neoplasm Diseases 0.000 claims description 26
- 101150029707 ERBB2 gene Proteins 0.000 claims description 21
- 230000003287 optical effect Effects 0.000 claims description 17
- 239000013642 negative control Substances 0.000 claims description 16
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 15
- 238000012360 testing method Methods 0.000 claims description 14
- 239000013641 positive control Substances 0.000 claims description 12
- 238000003860 storage Methods 0.000 claims description 12
- 102000005962 receptors Human genes 0.000 claims description 7
- 108020003175 receptors Proteins 0.000 claims description 7
- 208000026310 Breast neoplasm Diseases 0.000 claims description 5
- 238000004590 computer program Methods 0.000 claims description 4
- 206010006187 Breast cancer Diseases 0.000 claims description 3
- 229940046836 anti-estrogen Drugs 0.000 claims description 3
- 230000001833 anti-estrogenic effect Effects 0.000 claims description 3
- 239000000328 estrogen antagonist Substances 0.000 claims description 3
- 239000003418 antiprogestin Substances 0.000 claims description 2
- 230000003623 progesteronic effect Effects 0.000 claims description 2
- 208000035269 cancer or benign tumor Diseases 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 238000011002 quantification Methods 0.000 claims 1
- 210000004027 cell Anatomy 0.000 description 109
- 238000004458 analytical method Methods 0.000 description 56
- 230000008569 process Effects 0.000 description 54
- 238000003364 immunohistochemistry Methods 0.000 description 35
- 210000001519 tissue Anatomy 0.000 description 27
- 238000010186 staining Methods 0.000 description 26
- 230000006870 function Effects 0.000 description 23
- 238000010586 diagram Methods 0.000 description 21
- 238000012552 review Methods 0.000 description 20
- 210000004881 tumor cell Anatomy 0.000 description 19
- 230000000877 morphologic effect Effects 0.000 description 17
- 239000000523 sample Substances 0.000 description 17
- 239000011159 matrix material Substances 0.000 description 15
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 14
- 239000000969 carrier Substances 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 12
- 230000002829 reductive effect Effects 0.000 description 12
- 238000011068 loading method Methods 0.000 description 11
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 10
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 10
- 238000003556 assay Methods 0.000 description 10
- 238000005286 illumination Methods 0.000 description 10
- 239000000463 material Substances 0.000 description 10
- 201000011510 cancer Diseases 0.000 description 9
- 238000001914 filtration Methods 0.000 description 9
- 230000014509 gene expression Effects 0.000 description 9
- 238000010191 image analysis Methods 0.000 description 9
- 102000015694 estrogen receptors Human genes 0.000 description 8
- 108010038795 estrogen receptors Proteins 0.000 description 8
- 210000004940 nucleus Anatomy 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 102100025064 Cellular tumor antigen p53 Human genes 0.000 description 7
- 241000725303 Human immunodeficiency virus Species 0.000 description 6
- 241000700605 Viruses Species 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 238000003384 imaging method Methods 0.000 description 6
- 230000002055 immunohistochemical effect Effects 0.000 description 6
- 102000003998 progesterone receptors Human genes 0.000 description 6
- 108090000468 progesterone receptors Proteins 0.000 description 6
- 208000003788 Neoplasm Micrometastasis Diseases 0.000 description 5
- 230000000875 corresponding effect Effects 0.000 description 5
- 210000000805 cytoplasm Anatomy 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 5
- 230000007246 mechanism Effects 0.000 description 5
- 230000002018 overexpression Effects 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000008399 tap water Substances 0.000 description 5
- 235000020679 tap water Nutrition 0.000 description 5
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 4
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 4
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 4
- 239000000427 antigen Substances 0.000 description 4
- 108091007433 antigens Proteins 0.000 description 4
- 102000036639 antigens Human genes 0.000 description 4
- 210000000481 breast Anatomy 0.000 description 4
- 230000001413 cellular effect Effects 0.000 description 4
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 4
- 230000010339 dilation Effects 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 230000003628 erosive effect Effects 0.000 description 4
- 210000004088 microvessel Anatomy 0.000 description 4
- 230000001629 suppression Effects 0.000 description 4
- 230000004083 survival effect Effects 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 108700020796 Oncogene Proteins 0.000 description 3
- 102000003992 Peroxidases Human genes 0.000 description 3
- 102100034836 Proliferation marker protein Ki-67 Human genes 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000013060 biological fluid Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- MPBRYMWMMKKRGC-UHFFFAOYSA-M carbocyanin DBTC Chemical compound [Br-].C1=CC=CC2=C([N+](=C(C=C(C)C=C3N(C4=C5C=CC=CC5=CC=C4S3)CC)S3)CC)C3=CC=C21 MPBRYMWMMKKRGC-UHFFFAOYSA-M 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000006059 cover glass Substances 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 210000002919 epithelial cell Anatomy 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 238000012309 immunohistochemistry technique Methods 0.000 description 3
- 238000012744 immunostaining Methods 0.000 description 3
- 230000036210 malignancy Effects 0.000 description 3
- 210000000440 neutrophil Anatomy 0.000 description 3
- 108040007629 peroxidase activity proteins Proteins 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- 238000000844 transformation Methods 0.000 description 3
- 206010008342 Cervix carcinoma Diseases 0.000 description 2
- 101000945496 Homo sapiens Proliferation marker protein Ki-67 Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 206010027476 Metastases Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 2
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- WLDHEUZGFKACJH-UHFFFAOYSA-K amaranth Chemical compound [Na+].[Na+].[Na+].C12=CC=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(O)=C1N=NC1=CC=C(S([O-])(=O)=O)C2=CC=CC=C12 WLDHEUZGFKACJH-UHFFFAOYSA-K 0.000 description 2
- 230000033115 angiogenesis Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- 201000010881 cervical cancer Diseases 0.000 description 2
- 210000001072 colon Anatomy 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 210000005069 ears Anatomy 0.000 description 2
- 229940011871 estrogen Drugs 0.000 description 2
- 239000000262 estrogen Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 238000013394 immunophenotyping Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000011344 liquid material Substances 0.000 description 2
- XGZVUEUWXADBQD-UHFFFAOYSA-L lithium carbonate Chemical compound [Li+].[Li+].[O-]C([O-])=O XGZVUEUWXADBQD-UHFFFAOYSA-L 0.000 description 2
- 229910052808 lithium carbonate Inorganic materials 0.000 description 2
- 210000001165 lymph node Anatomy 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 230000009401 metastasis Effects 0.000 description 2
- 230000001394 metastastic effect Effects 0.000 description 2
- 206010061289 metastatic neoplasm Diseases 0.000 description 2
- 230000000394 mitotic effect Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 210000005259 peripheral blood Anatomy 0.000 description 2
- 239000011886 peripheral blood Substances 0.000 description 2
- 239000000186 progesterone Substances 0.000 description 2
- 229960003387 progesterone Drugs 0.000 description 2
- 238000004445 quantitative analysis Methods 0.000 description 2
- 210000001995 reticulocyte Anatomy 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 241001092081 Carpenteria Species 0.000 description 1
- 206010008263 Cervical dysplasia Diseases 0.000 description 1
- 206010008805 Chromosomal abnormalities Diseases 0.000 description 1
- 208000031404 Chromosome Aberrations Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010058314 Dysplasia Diseases 0.000 description 1
- 206010063045 Effusion Diseases 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 102000009465 Growth Factor Receptors Human genes 0.000 description 1
- 108010009202 Growth Factor Receptors Proteins 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 108010020437 Ki-67 Antigen Proteins 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 208000007660 Residual Neoplasm Diseases 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 239000001164 aluminium sulphate Substances 0.000 description 1
- 235000011128 aluminium sulphate Nutrition 0.000 description 1
- 210000004381 amniotic fluid Anatomy 0.000 description 1
- 238000004164 analytical calibration Methods 0.000 description 1
- 230000036436 anti-hiv Effects 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 201000008275 breast carcinoma Diseases 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000003855 cell nucleus Anatomy 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000023549 cell-cell signaling Effects 0.000 description 1
- 210000003679 cervix uteri Anatomy 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000004883 computer application Methods 0.000 description 1
- 230000001268 conjugating effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000013016 damping Methods 0.000 description 1
- 238000013479 data entry Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000007435 diagnostic evaluation Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- BUACSMWVFUNQET-UHFFFAOYSA-H dialuminum;trisulfate;hydrate Chemical compound O.[Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O BUACSMWVFUNQET-UHFFFAOYSA-H 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 230000004077 genetic alteration Effects 0.000 description 1
- 231100000118 genetic alteration Toxicity 0.000 description 1
- 210000002816 gill Anatomy 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002962 histologic effect Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 238000001794 hormone therapy Methods 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000002991 immunohistochemical analysis Methods 0.000 description 1
- 238000012308 immunohistochemistry method Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000011005 laboratory method Methods 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000008802 morphological function Effects 0.000 description 1
- 210000001087 myotubule Anatomy 0.000 description 1
- NALMPLUMOWIVJC-UHFFFAOYSA-N n,n,4-trimethylbenzeneamine oxide Chemical compound CC1=CC=C([N+](C)(C)[O-])C=C1 NALMPLUMOWIVJC-UHFFFAOYSA-N 0.000 description 1
- 230000009826 neoplastic cell growth Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- IPSIPYMEZZPCPY-UHFFFAOYSA-N new fuchsin Chemical compound [Cl-].C1=CC(=[NH2+])C(C)=CC1=C(C=1C=C(C)C(N)=CC=1)C1=CC=C(N)C(C)=C1 IPSIPYMEZZPCPY-UHFFFAOYSA-N 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000013610 patient sample Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 238000003793 prenatal diagnosis Methods 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 230000004952 protein activity Effects 0.000 description 1
- 238000000275 quality assurance Methods 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000015281 sodium iodate Nutrition 0.000 description 1
- 239000011697 sodium iodate Substances 0.000 description 1
- 229940032753 sodium iodate Drugs 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 102000005969 steroid hormone receptors Human genes 0.000 description 1
- 108020003113 steroid hormone receptors Proteins 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
- G01N1/31—Apparatus therefor
- G01N1/312—Apparatus therefor for samples mounted on planar substrates
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06V—IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING
- G06V20/00—Scenes; Scene-specific elements
- G06V20/60—Type of objects
- G06V20/69—Microscopic objects, e.g. biological cells or cellular parts
Definitions
- the invention relates generally to light
- microscopy and, more particularly, to automated light
- biological specimen such as bone marrow, lymph nodes,
- peripheral blood cerebrospinal fluid, urine,
- method of cell specimen preparation is to react a
- nucleic acid which is reactive with a component of
- the cells of interest such as tumor cells.
- reaction may be detected using an enzymatic reaction
- alkaline phosphatase such as alkaline phosphatase or glucose oxidase or
- HER2 (neu) is a growth factor receptor and
- hybridization methods are typically used for HER2/neu
- rare events e.g., finding one tumor cell in a
- the present invention provides a method
- a slide carrier which preferably holds
- the slide carriers are loaded into an
- the system automatically locates a scan area for each slide during slide processing.
- magnification image is acquired and processed to
- a high magnification image is
- control slides including positive
- candidate objects of interest for a slide may be
- cytotechnologist may view the mosaic or may also
- the mosaic may be stored on magnetic media for future
- invention preferably includes the steps of
- thresholded image to determine the presence of one or
- the scan area is automatically determined by scanning
- the derived focal plane enables subsequent
- the focal plane is determined by
- a focal plane across the array Preferably, a focal plane
- acquired image is calculated to form a set of
- the region of interest is a region of interest
- n preferably n columns wide, where n is a power of 2.
- the pixels of this region are then processed using a
- a slide is mounted onto a
- the slide carrier is positioned in an input
- the invention is a HER2/neu expression in tissue.
- tissue especially breast tissue.
- FIG. 1 is a perspective view of an apparatus for
- Fig. 2 is a block diagram of the apparatus shown
- Fig. 3 is a block diagram of the microscope
- Fig. 4 is a plan view of the apparatus of Fig. 1
- Fig. 5 is a side view of a microscope subsystem
- Fig. 6a is a top view of a slide carrier for use
- Fig. 6b is a bottom view of the slide carrier of
- Fig. 7a is a top view of an automated slide
- Fig. 7b is a partial cross-sectional view of the
- Fig. 8 is an end view of the input module of the
- Fig. 9a-9d illustrate the output operation of
- Fig. 10 is a flow diagram of the procedure for
- Fig. 11 shows the scan path on a prepared slide
- Fig. 12 illustrates an image of a field acquired
- Fig. 13A is a flow diagram of a preferred embodiment
- Fig. 13B is a flow diagram of a preferred embodiment
- Fig. 14 is a flow diagram of a procedure for
- Fig. 15 shows an array of slide positions for
- Fig. 16 is a flow diagram of a procedure for
- Fig. 17A is a flow diagram of an overview of the
- Fig. 17B is a flow diagram of a procedure for
- Fig. 18 is a flow diagram of a procedure for
- Fig. 19 is a flow diagram of a procedure for
- Fig. 20 is a flow diagram of a procedure for
- Fig. 21 is a flow diagram of a procedure for
- Fig. 22 illustrates a mosaic of cell images
- Fig. 23 is a flow diagram of a procedure for
- Fig. 24 illustrates the apparatus functions
- the invention provides an automated tissue image
- proliferative disorder for example those associated with
- MIB-I Microvessel density analysis, the oncogene
- nucleoli HIV p24
- HPV human papiloma virus
- mitotic index generally any combination
- ACISTM Cellular Imaging System
- a worklist is a group of
- a specimen group consists of
- H/E staining protocol is compatible with
- the specimen may
- third antibody i.e., patient negative
- This calibration consists of radiometric
- the output of the worklist is a stained
- a cellular specimen (a "sample") is split to
- sample provides two or more subsamples.
- sample provides two or more subsamples.
- cellular material derived from a subject includes cellular material derived from a subject.
- Such samples include but are not limited to hair,
- tissue refers to a mass of connected cells (e.g.,
- biological fluid refers to liquid material derived from a
- sample also includes media containing isolated
- reaction may be determined by one skilled in the art
- the HER2/neu method uses an anti-HER2/neu
- kit like that provided by DAKO (Carpinteria, CA) .
- slide includes a cover-slip medium to protect the
- coverslip covers the entire prepared specimen.
- control slides are run with every worklist. The set
- H/E hematoxylin/eosin
- the staining procedure is as follows: (1) Bring
- the invention also provides automated methods
- the estrogen and progesterone receptors The estrogen and progesterone receptors,
- immunohistochemistry system such as that provided by
- a micrometastases is
- metastatic recurring disease is similar to
- micrometastasis but is detected after cancer therapy
- MIB-1 is an antibody that can be used in
- the clinical stage at first presentation is related
- metastasis death from neoplasia, low disease-free
- Angiogenesis is a complex regional vascular endothelial fibroblast fibroblast fibroblast fibroblast fibroblast fibroblast fibroblast fibroblast fibroblast fibroblast fibroblast fibroblast fibroblast fibroblast fibroblast fibroblast fibroblast fibroblast fibroblast fibroblast fibroblast fibroblast fibroblast fibroblast fibroblast fibroblast fibroblast fibroblast fibroblast fibroblast fibroblast fibroblast fibroblasts, hematoma, hematoma, hematoma, hematoma, hematoma hematoma hematoma hematoma hematoma hematoma hematoma hematoma hematoma hematoma hematoma hematoma hematoma hematoma hematoma hematoma hematoma hematoma hematoma hematoma hematoma hematoma hematoma hematoma hematoma hematoma hematoma hematoma hematoma hem
- Intratumor microvessel density can be assessed by anti-CD34
- malignancies including neoplasms of breast, colon,
- p53 is performed using an anti-p53 antibody, for
- a nucleoli is an
- Cervical dysplasia Cervical dysplasia
- dysplastic cells are of the same kind but of a lesser amount
- HIV HIV p24 antigen levels
- the HIV p24 protein test is used for the
- the test can be used to detect the virus, measure the amount of virus, and
- HPV Human Papiloma Virus
- HPV transmitted virus which causes warts .
- the patient data entry interface is
- HER2/neu is composed of tissue samples that are
- One slide is prepared with the HER2/neu
- worklist is the: (1) worklist name or identifier of protocol (e.g., HER2/neu) ; barcode of the positive
- Case is the: (4) patient ID; (5) accession number;
- the input hopper is composed of all the
- the system reads industry standard barcodes .
- the barcode relates the type of protocol the
- the HER2-positive application (1) finds the
- the HER2-negative application (1) finds the
- the HER2 application (1) finds the specimen, (2)
- the Slide Display Interface displays the list of
- the set of patient slides is a
- H/E image is
- pathologist determines whether or not the cancer is
- This image is displayed. This image can be reduced to
- the pathologist can have the features available
- the pathologist has the following capabilities: (1)
- pathologist has the following capabilities: (1) to
- a User Interface lists all the patient cases that have already been reviewed and analyzed by
- the pathologist can choose one or
- the interface that displays the patient reports
- Network connectivity is site specific.
- Site specificity is desired for sending reports via
- the instrument can have at least two user modes .
- One user mode is a locked protocol consistent with
- a second user mode is modifiable by
- the apparatus 10 comprises a
- microscope subsystem 32 housed in a housing 12.
- housing 12 includes a slide carrier input hopper 16
- the housing 12 secures the microscope subsystem from
- the computer subsystem further includes a computer
- peripherals including storage device 21, pointing
- external power supply 24 is also shown for powering
- the apparatus 10 further includes a CCD camera 42 for acquiring images through the microscope
- control of system processor 23 controls a number of
- controller 31 provides displacement of the microscope
- microscope subsystem 32 further includes a motorized
- objective turret 44 for selection of objectives.
- the purpose of the apparatus 10 is for the
- tumor cells e.g., tumor cells.
- the preferred embodiment may be utilized for rare event detection in which
- biological specimen may be prepared with a reagent to
- apparatus of the present invention is used to detect
- a slide carrier 60 is illustrated in
- Each slide carrier holds up to 4 slides. Up to 25 slide
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00947299A EP1203343A4 (fr) | 1999-07-13 | 2000-07-12 | Detection automatique d'objets dans un echantillon biologique |
JP2001510159A JP2003504627A (ja) | 1999-07-13 | 2000-07-12 | 生物試料中の物体の自動検出 |
AU60934/00A AU6093400A (en) | 1999-07-13 | 2000-07-12 | Automated detection of objects in a biological sample |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14382399P | 1999-07-13 | 1999-07-13 | |
US60/143,823 | 1999-07-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2001004828A1 true WO2001004828A1 (fr) | 2001-01-18 |
Family
ID=22505818
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/019046 WO2001004828A1 (fr) | 1999-07-13 | 2000-07-12 | Detection automatique d'objets dans un echantillon biologique |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1203343A4 (fr) |
JP (1) | JP2003504627A (fr) |
AU (1) | AU6093400A (fr) |
WO (1) | WO2001004828A1 (fr) |
Cited By (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004013658A2 (fr) * | 2002-07-30 | 2004-02-12 | Deutsches Krebsforschungszentrum | Procede et appareil de detection par etiquetage multiple et d'evaluation d'une pluralite de particules |
WO2004017052A3 (fr) * | 2002-08-15 | 2004-06-03 | Qinetiq Ltd | Estimation histologique |
WO2004051554A1 (fr) | 2002-11-27 | 2004-06-17 | 3M Innovative Properties Company | Dispositif de balayage de plaques de culture biologique avec selection automatisee de profils de traitement d'images |
GB2400205A (en) * | 2003-03-05 | 2004-10-06 | Fairfield Imaging Ltd | Analysis of pathological samples and provision of digital images relating to the samples |
EP1572979A1 (fr) * | 2002-12-20 | 2005-09-14 | DakoCytomation Denmark A/S | Procede et appareil de coloration automatique d'echantillons de tissu |
EP1804046A2 (fr) * | 2005-12-28 | 2007-07-04 | Sysmex Corporation | Appareil permettant l'obtention d'images d'échantillons, système permettant l'obtention d'images d'échantillons et procédé permettant l'obtention d'images d'échantillons |
EP1845359A2 (fr) * | 2001-10-29 | 2007-10-17 | Pola Chemical Industries, Inc. | Procédé de coloration de cornéocytes, procédés pour la préparation d'un spécimen de cornéocyte et système d'analyse de la peau |
JP2010060564A (ja) * | 2002-08-15 | 2010-03-18 | Qinetiq Ltd | 組織学的アセスメント |
CN102362168A (zh) * | 2009-03-27 | 2012-02-22 | 索尼公司 | 观察设备 |
EP1927860A3 (fr) * | 2006-11-30 | 2013-03-06 | Sysmex Corporation | Analyseur d'images de sang |
US8922781B2 (en) | 2004-11-29 | 2014-12-30 | The General Hospital Corporation | Arrangements, devices, endoscopes, catheters and methods for performing optical imaging by simultaneously illuminating and detecting multiple points on a sample |
US8928889B2 (en) | 2005-09-29 | 2015-01-06 | The General Hospital Corporation | Arrangements and methods for providing multimodality microscopic imaging of one or more biological structures |
US9060689B2 (en) | 2005-06-01 | 2015-06-23 | The General Hospital Corporation | Apparatus, method and system for performing phase-resolved optical frequency domain imaging |
US9069130B2 (en) | 2010-05-03 | 2015-06-30 | The General Hospital Corporation | Apparatus, method and system for generating optical radiation from biological gain media |
US9186066B2 (en) | 2006-02-01 | 2015-11-17 | The General Hospital Corporation | Apparatus for applying a plurality of electro-magnetic radiations to a sample |
US9282931B2 (en) | 2000-10-30 | 2016-03-15 | The General Hospital Corporation | Methods for tissue analysis |
US9330092B2 (en) | 2011-07-19 | 2016-05-03 | The General Hospital Corporation | Systems, methods, apparatus and computer-accessible-medium for providing polarization-mode dispersion compensation in optical coherence tomography |
US9326682B2 (en) | 2005-04-28 | 2016-05-03 | The General Hospital Corporation | Systems, processes and software arrangements for evaluating information associated with an anatomical structure by an optical coherence ranging technique |
US9341783B2 (en) | 2011-10-18 | 2016-05-17 | The General Hospital Corporation | Apparatus and methods for producing and/or providing recirculating optical delay(s) |
EP2946198A4 (fr) * | 2013-01-21 | 2016-07-27 | Univ Cornell | Appareil basé sur un téléphone intelligent, et procédé pour l'obtention de mesures colorimétriques quantitatives, répétables |
US9408539B2 (en) | 2010-03-05 | 2016-08-09 | The General Hospital Corporation | Systems, methods and computer-accessible medium which provide microscopic images of at least one anatomical structure at a particular resolution |
US9415550B2 (en) | 2012-08-22 | 2016-08-16 | The General Hospital Corporation | System, method, and computer-accessible medium for fabrication miniature endoscope using soft lithography |
US9441948B2 (en) | 2005-08-09 | 2016-09-13 | The General Hospital Corporation | Apparatus, methods and storage medium for performing polarization-based quadrature demodulation in optical coherence tomography |
US9510758B2 (en) | 2010-10-27 | 2016-12-06 | The General Hospital Corporation | Apparatus, systems and methods for measuring blood pressure within at least one vessel |
US9516997B2 (en) | 2006-01-19 | 2016-12-13 | The General Hospital Corporation | Spectrally-encoded endoscopy techniques, apparatus and methods |
US9541504B2 (en) | 2010-08-05 | 2017-01-10 | Cambridge Research & Instrumentation, Inc. | Enhancing visual assessment of samples |
US9557154B2 (en) | 2010-05-25 | 2017-01-31 | The General Hospital Corporation | Systems, devices, methods, apparatus and computer-accessible media for providing optical imaging of structures and compositions |
US9615748B2 (en) | 2009-01-20 | 2017-04-11 | The General Hospital Corporation | Endoscopic biopsy apparatus, system and method |
US9629528B2 (en) | 2012-03-30 | 2017-04-25 | The General Hospital Corporation | Imaging system, method and distal attachment for multidirectional field of view endoscopy |
USRE46412E1 (en) | 2006-02-24 | 2017-05-23 | The General Hospital Corporation | Methods and systems for performing angle-resolved Fourier-domain optical coherence tomography |
US9664615B2 (en) | 2004-07-02 | 2017-05-30 | The General Hospital Corporation | Imaging system and related techniques |
US9733460B2 (en) | 2014-01-08 | 2017-08-15 | The General Hospital Corporation | Method and apparatus for microscopic imaging |
US9763623B2 (en) | 2004-08-24 | 2017-09-19 | The General Hospital Corporation | Method and apparatus for imaging of vessel segments |
US9784681B2 (en) | 2013-05-13 | 2017-10-10 | The General Hospital Corporation | System and method for efficient detection of the phase and amplitude of a periodic modulation associated with self-interfering fluorescence |
US9795301B2 (en) | 2010-05-25 | 2017-10-24 | The General Hospital Corporation | Apparatus, systems, methods and computer-accessible medium for spectral analysis of optical coherence tomography images |
US9933446B2 (en) | 2008-03-04 | 2018-04-03 | 3M Innovative Properties Company | Processing of biological growth media based on measured manufacturing characteristics |
US9968245B2 (en) | 2006-10-19 | 2018-05-15 | The General Hospital Corporation | Apparatus and method for obtaining and providing imaging information associated with at least one portion of a sample, and effecting such portion(s) |
US9968261B2 (en) | 2013-01-28 | 2018-05-15 | The General Hospital Corporation | Apparatus and method for providing diffuse spectroscopy co-registered with optical frequency domain imaging |
US10058250B2 (en) | 2013-07-26 | 2018-08-28 | The General Hospital Corporation | System, apparatus and method for utilizing optical dispersion for fourier-domain optical coherence tomography |
US10117576B2 (en) | 2013-07-19 | 2018-11-06 | The General Hospital Corporation | System, method and computer accessible medium for determining eye motion by imaging retina and providing feedback for acquisition of signals from the retina |
US10169861B2 (en) | 2013-12-27 | 2019-01-01 | Fujifilm Corporation | Image processing apparatus, non-transitory computer readable medium, and image processing method |
US10228556B2 (en) | 2014-04-04 | 2019-03-12 | The General Hospital Corporation | Apparatus and method for controlling propagation and/or transmission of electromagnetic radiation in flexible waveguide(s) |
US10285568B2 (en) | 2010-06-03 | 2019-05-14 | The General Hospital Corporation | Apparatus and method for devices for imaging structures in or at one or more luminal organs |
US10413175B2 (en) | 2006-05-10 | 2019-09-17 | The General Hospital Corporation | Process, arrangements and systems for providing frequency domain imaging of a sample |
US10426548B2 (en) | 2006-02-01 | 2019-10-01 | The General Hosppital Corporation | Methods and systems for providing electromagnetic radiation to at least one portion of a sample using conformal laser therapy procedures |
US10478072B2 (en) | 2013-03-15 | 2019-11-19 | The General Hospital Corporation | Methods and system for characterizing an object |
US10736494B2 (en) | 2014-01-31 | 2020-08-11 | The General Hospital Corporation | System and method for facilitating manual and/or automatic volumetric imaging with real-time tension or force feedback using a tethered imaging device |
US10835110B2 (en) | 2008-07-14 | 2020-11-17 | The General Hospital Corporation | Apparatus and method for facilitating at least partial overlap of dispersed ration on at least one sample |
US10893806B2 (en) | 2013-01-29 | 2021-01-19 | The General Hospital Corporation | Apparatus, systems and methods for providing information regarding the aortic valve |
US10912462B2 (en) | 2014-07-25 | 2021-02-09 | The General Hospital Corporation | Apparatus, devices and methods for in vivo imaging and diagnosis |
US11179028B2 (en) | 2013-02-01 | 2021-11-23 | The General Hospital Corporation | Objective lens arrangement for confocal endomicroscopy |
US11452433B2 (en) | 2013-07-19 | 2022-09-27 | The General Hospital Corporation | Imaging apparatus and method which utilizes multidirectional field of view endoscopy |
US11490797B2 (en) | 2012-05-21 | 2022-11-08 | The General Hospital Corporation | Apparatus, device and method for capsule microscopy |
US11490826B2 (en) | 2009-07-14 | 2022-11-08 | The General Hospital Corporation | Apparatus, systems and methods for measuring flow and pressure within a vessel |
CN115541578A (zh) * | 2022-09-28 | 2022-12-30 | 佐健(上海)生物医疗科技有限公司 | 一种高通量超分辨宫颈细胞病理切片快速扫描分析系统 |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2333521B1 (fr) | 2001-04-30 | 2019-12-04 | The General Hospital Corporation | Procédé et appareil permettant d'améliorer la clarté et la sensibilité de l'image en tomographie à cohérence optique au moyen d'une interaction permettant de contrôler les propriétés focales et la synchronisation de cohérence |
US7567349B2 (en) | 2003-03-31 | 2009-07-28 | The General Hospital Corporation | Speckle reduction in optical coherence tomography by path length encoded angular compounding |
ES2310744T3 (es) | 2003-06-06 | 2009-01-16 | The General Hospital Corporation | Fuente de luz sintonizable en longitudes de onda. |
DE102004009934A1 (de) * | 2004-02-26 | 2005-09-22 | Niendorf, Axel, Prof.Dr.med. | Verfahren zur Untersuchung einer Gewebeprobe |
EP1989997A1 (fr) | 2004-08-24 | 2008-11-12 | The General Hospital Corporation | Procèdé, Système et logiciel pour la mesure de la contrainte mécanique et des propriétés élastiques d'un echantillon |
US20060159367A1 (en) * | 2005-01-18 | 2006-07-20 | Trestle Corporation | System and method for creating variable quality images of a slide |
JPWO2007013551A1 (ja) * | 2005-07-29 | 2009-02-12 | オリンパス株式会社 | 光強度測定方法および光強度測定装置 |
EP2289397A3 (fr) | 2006-01-19 | 2011-04-06 | The General Hospital Corporation | Procédés et systèmes pour visualiser de manière optique des organes intracavitaires épithéliaux lors d'un balayage au faisceau |
EP2042853B1 (fr) * | 2006-07-12 | 2014-04-23 | Toyobo Co., Ltd. | Analyseur et son utilisation |
JP4938428B2 (ja) * | 2006-12-01 | 2012-05-23 | シスメックス株式会社 | 標本画像作成方法及び装置 |
JP5663873B2 (ja) * | 2007-03-01 | 2015-02-04 | 日本電気株式会社 | 乳癌病理画像診断支援システム、乳癌病理画像診断支援方法、乳癌病理画像診断支援プログラム、及び、乳癌病理画像診断支援プログラムを記録した記録媒体 |
US9176319B2 (en) | 2007-03-23 | 2015-11-03 | The General Hospital Corporation | Methods, arrangements and apparatus for utilizing a wavelength-swept laser using angular scanning and dispersion procedures |
WO2008121844A1 (fr) | 2007-03-30 | 2008-10-09 | The General Hospital Corporation | Système et procédé pour fournir une imagerie à granularité laser en vue de détecter une plaque à risque |
WO2009018456A2 (fr) | 2007-07-31 | 2009-02-05 | The General Hospital Corporation | Systèmes et procédés pour fournir des motifs de balayage de faisceau pour une imagerie dans le domaine de la fréquence optique doppler de vitesse élevée |
CH708797B1 (de) * | 2007-08-17 | 2015-05-15 | Tecan Trading Ag | Probenteil-Magazin für eine Objektträger-Transportvorrichtung eines Laser Scanner-Geräts. |
WO2009125547A1 (fr) * | 2008-04-09 | 2009-10-15 | 株式会社ニコン | Régulateur d'appareil de culture et programme de régulation |
WO2010068764A2 (fr) | 2008-12-10 | 2010-06-17 | The General Hospital Corporation | Systèmes, appareil et procédés d'extension de la plage de profondeur d'imagerie de tomographie par cohérence optique, par le biais du sous-échantillonnage optique |
WO2010091190A2 (fr) | 2009-02-04 | 2010-08-12 | The General Hospital Corporation | Appareil et procédé d'utilisation d'une source d'ajustement de longueur d'onde optique à grande vitesse |
KR102492083B1 (ko) * | 2021-10-21 | 2023-01-27 | 주식회사 이뮤니스바이오 | 세포 카운트 방법 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5428690A (en) * | 1991-09-23 | 1995-06-27 | Becton Dickinson And Company | Method and apparatus for automated assay of biological specimens |
US5889881A (en) * | 1992-10-14 | 1999-03-30 | Oncometrics Imaging Corp. | Method and apparatus for automatically detecting malignancy-associated changes |
US5888742A (en) * | 1997-10-28 | 1999-03-30 | Incyte Pharmaceuticals, Inc. | Human phospholipid binding proteins |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW203120B (fr) * | 1985-10-04 | 1993-04-01 | Abbott Lab | |
JP2873015B2 (ja) * | 1989-04-27 | 1999-03-24 | 株式会社京都第一科学 | 分析装置 |
US6215892B1 (en) * | 1995-11-30 | 2001-04-10 | Chromavision Medical Systems, Inc. | Method and apparatus for automated image analysis of biological specimens |
-
2000
- 2000-07-12 EP EP00947299A patent/EP1203343A4/fr not_active Withdrawn
- 2000-07-12 AU AU60934/00A patent/AU6093400A/en not_active Abandoned
- 2000-07-12 WO PCT/US2000/019046 patent/WO2001004828A1/fr not_active Application Discontinuation
- 2000-07-12 JP JP2001510159A patent/JP2003504627A/ja active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5428690A (en) * | 1991-09-23 | 1995-06-27 | Becton Dickinson And Company | Method and apparatus for automated assay of biological specimens |
US5889881A (en) * | 1992-10-14 | 1999-03-30 | Oncometrics Imaging Corp. | Method and apparatus for automatically detecting malignancy-associated changes |
US5888742A (en) * | 1997-10-28 | 1999-03-30 | Incyte Pharmaceuticals, Inc. | Human phospholipid binding proteins |
Non-Patent Citations (1)
Title |
---|
See also references of EP1203343A4 * |
Cited By (73)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9282931B2 (en) | 2000-10-30 | 2016-03-15 | The General Hospital Corporation | Methods for tissue analysis |
EP1845359A2 (fr) * | 2001-10-29 | 2007-10-17 | Pola Chemical Industries, Inc. | Procédé de coloration de cornéocytes, procédés pour la préparation d'un spécimen de cornéocyte et système d'analyse de la peau |
US7425427B2 (en) | 2001-10-29 | 2008-09-16 | Pola Chemical Industries Inc. | Method for staining corneocytes, method for preparing corneocytes specimen and skin analysis system |
US7421105B2 (en) | 2001-10-29 | 2008-09-02 | Pola Chemical Industries Inc. | Method for staining corneocytes, method for preparing corneocytes specimen and skin analysis system |
EP1845359A3 (fr) * | 2001-10-29 | 2007-11-14 | Pola Chemical Industries, Inc. | Procédé de coloration de cornéocytes, procédés pour la préparation d'un spécimen de cornéocyte et système d'analyse de la peau |
WO2004013658A3 (fr) * | 2002-07-30 | 2004-05-21 | Steinbeis Transferzentrum Anal | Procede et appareil de detection par etiquetage multiple et d'evaluation d'une pluralite de particules |
WO2004013658A2 (fr) * | 2002-07-30 | 2004-02-12 | Deutsches Krebsforschungszentrum | Procede et appareil de detection par etiquetage multiple et d'evaluation d'une pluralite de particules |
JP2010060564A (ja) * | 2002-08-15 | 2010-03-18 | Qinetiq Ltd | 組織学的アセスメント |
US7079675B2 (en) | 2002-08-15 | 2006-07-18 | Qinetiq Limited | Histological assessment |
WO2004017052A3 (fr) * | 2002-08-15 | 2004-06-03 | Qinetiq Ltd | Estimation histologique |
EP1573654A1 (fr) * | 2002-11-27 | 2005-09-14 | 3M Innovative Properties Company | Dispositif de balayage de plaques de culture biologique avec sélection automatisée de profils de traitement d'images |
EP1573654A4 (fr) * | 2002-11-27 | 2007-12-12 | 3M Innovative Properties Co | Dispositif de balayage de plaques de culture biologique avec sélection automatisée de profils de traitement d'images |
US7901933B2 (en) | 2002-11-27 | 2011-03-08 | 3M Innovative Properties Company | Methods of processing a biological growth plate in a biological growth plate scanner |
EP2325778A1 (fr) * | 2002-11-27 | 2011-05-25 | 3M Innovative Properties Company | Dispositif de balayage de plaques de culture biologique avec sélection automatisée de profils de traitement d'images |
WO2004051554A1 (fr) | 2002-11-27 | 2004-06-17 | 3M Innovative Properties Company | Dispositif de balayage de plaques de culture biologique avec selection automatisee de profils de traitement d'images |
EP1572979A1 (fr) * | 2002-12-20 | 2005-09-14 | DakoCytomation Denmark A/S | Procede et appareil de coloration automatique d'echantillons de tissu |
EP1572979A4 (fr) * | 2002-12-20 | 2011-10-19 | Dakocytomation Denmark As | Procede et appareil de coloration automatique d'echantillons de tissu |
US9599630B2 (en) | 2002-12-20 | 2017-03-21 | Dako Denmark A/S | Method and apparatus for automatic staining of tissue samples |
GB2400205A (en) * | 2003-03-05 | 2004-10-06 | Fairfield Imaging Ltd | Analysis of pathological samples and provision of digital images relating to the samples |
US9664615B2 (en) | 2004-07-02 | 2017-05-30 | The General Hospital Corporation | Imaging system and related techniques |
US9763623B2 (en) | 2004-08-24 | 2017-09-19 | The General Hospital Corporation | Method and apparatus for imaging of vessel segments |
US8922781B2 (en) | 2004-11-29 | 2014-12-30 | The General Hospital Corporation | Arrangements, devices, endoscopes, catheters and methods for performing optical imaging by simultaneously illuminating and detecting multiple points on a sample |
US9326682B2 (en) | 2005-04-28 | 2016-05-03 | The General Hospital Corporation | Systems, processes and software arrangements for evaluating information associated with an anatomical structure by an optical coherence ranging technique |
US9060689B2 (en) | 2005-06-01 | 2015-06-23 | The General Hospital Corporation | Apparatus, method and system for performing phase-resolved optical frequency domain imaging |
US9441948B2 (en) | 2005-08-09 | 2016-09-13 | The General Hospital Corporation | Apparatus, methods and storage medium for performing polarization-based quadrature demodulation in optical coherence tomography |
US8928889B2 (en) | 2005-09-29 | 2015-01-06 | The General Hospital Corporation | Arrangements and methods for providing multimodality microscopic imaging of one or more biological structures |
US9513276B2 (en) | 2005-09-29 | 2016-12-06 | The General Hospital Corporation | Method and apparatus for optical imaging via spectral encoding |
EP1804046A3 (fr) * | 2005-12-28 | 2013-02-20 | Sysmex Corporation | Appareil permettant l'obtention d'images d'échantillons, système permettant l'obtention d'images d'échantillons et procédé permettant l'obtention d'images d'échantillons |
EP1804046A2 (fr) * | 2005-12-28 | 2007-07-04 | Sysmex Corporation | Appareil permettant l'obtention d'images d'échantillons, système permettant l'obtention d'images d'échantillons et procédé permettant l'obtention d'images d'échantillons |
US9516997B2 (en) | 2006-01-19 | 2016-12-13 | The General Hospital Corporation | Spectrally-encoded endoscopy techniques, apparatus and methods |
US10426548B2 (en) | 2006-02-01 | 2019-10-01 | The General Hosppital Corporation | Methods and systems for providing electromagnetic radiation to at least one portion of a sample using conformal laser therapy procedures |
US9186066B2 (en) | 2006-02-01 | 2015-11-17 | The General Hospital Corporation | Apparatus for applying a plurality of electro-magnetic radiations to a sample |
USRE46412E1 (en) | 2006-02-24 | 2017-05-23 | The General Hospital Corporation | Methods and systems for performing angle-resolved Fourier-domain optical coherence tomography |
US10413175B2 (en) | 2006-05-10 | 2019-09-17 | The General Hospital Corporation | Process, arrangements and systems for providing frequency domain imaging of a sample |
US9968245B2 (en) | 2006-10-19 | 2018-05-15 | The General Hospital Corporation | Apparatus and method for obtaining and providing imaging information associated with at least one portion of a sample, and effecting such portion(s) |
EP1927860A3 (fr) * | 2006-11-30 | 2013-03-06 | Sysmex Corporation | Analyseur d'images de sang |
US9933446B2 (en) | 2008-03-04 | 2018-04-03 | 3M Innovative Properties Company | Processing of biological growth media based on measured manufacturing characteristics |
US10835110B2 (en) | 2008-07-14 | 2020-11-17 | The General Hospital Corporation | Apparatus and method for facilitating at least partial overlap of dispersed ration on at least one sample |
US9615748B2 (en) | 2009-01-20 | 2017-04-11 | The General Hospital Corporation | Endoscopic biopsy apparatus, system and method |
CN102362168A (zh) * | 2009-03-27 | 2012-02-22 | 索尼公司 | 观察设备 |
US11490826B2 (en) | 2009-07-14 | 2022-11-08 | The General Hospital Corporation | Apparatus, systems and methods for measuring flow and pressure within a vessel |
US10463254B2 (en) | 2010-03-05 | 2019-11-05 | The General Hospital Corporation | Light tunnel and lens which provide extended focal depth of at least one anatomical structure at a particular resolution |
US9642531B2 (en) | 2010-03-05 | 2017-05-09 | The General Hospital Corporation | Systems, methods and computer-accessible medium which provide microscopic images of at least one anatomical structure at a particular resolution |
US9408539B2 (en) | 2010-03-05 | 2016-08-09 | The General Hospital Corporation | Systems, methods and computer-accessible medium which provide microscopic images of at least one anatomical structure at a particular resolution |
US9951269B2 (en) | 2010-05-03 | 2018-04-24 | The General Hospital Corporation | Apparatus, method and system for generating optical radiation from biological gain media |
US9069130B2 (en) | 2010-05-03 | 2015-06-30 | The General Hospital Corporation | Apparatus, method and system for generating optical radiation from biological gain media |
US9795301B2 (en) | 2010-05-25 | 2017-10-24 | The General Hospital Corporation | Apparatus, systems, methods and computer-accessible medium for spectral analysis of optical coherence tomography images |
US9557154B2 (en) | 2010-05-25 | 2017-01-31 | The General Hospital Corporation | Systems, devices, methods, apparatus and computer-accessible media for providing optical imaging of structures and compositions |
US10939825B2 (en) | 2010-05-25 | 2021-03-09 | The General Hospital Corporation | Systems, devices, methods, apparatus and computer-accessible media for providing optical imaging of structures and compositions |
US10285568B2 (en) | 2010-06-03 | 2019-05-14 | The General Hospital Corporation | Apparatus and method for devices for imaging structures in or at one or more luminal organs |
US9541504B2 (en) | 2010-08-05 | 2017-01-10 | Cambridge Research & Instrumentation, Inc. | Enhancing visual assessment of samples |
US9510758B2 (en) | 2010-10-27 | 2016-12-06 | The General Hospital Corporation | Apparatus, systems and methods for measuring blood pressure within at least one vessel |
US9330092B2 (en) | 2011-07-19 | 2016-05-03 | The General Hospital Corporation | Systems, methods, apparatus and computer-accessible-medium for providing polarization-mode dispersion compensation in optical coherence tomography |
US9341783B2 (en) | 2011-10-18 | 2016-05-17 | The General Hospital Corporation | Apparatus and methods for producing and/or providing recirculating optical delay(s) |
US9629528B2 (en) | 2012-03-30 | 2017-04-25 | The General Hospital Corporation | Imaging system, method and distal attachment for multidirectional field of view endoscopy |
US11490797B2 (en) | 2012-05-21 | 2022-11-08 | The General Hospital Corporation | Apparatus, device and method for capsule microscopy |
US9415550B2 (en) | 2012-08-22 | 2016-08-16 | The General Hospital Corporation | System, method, and computer-accessible medium for fabrication miniature endoscope using soft lithography |
EP2946198A4 (fr) * | 2013-01-21 | 2016-07-27 | Univ Cornell | Appareil basé sur un téléphone intelligent, et procédé pour l'obtention de mesures colorimétriques quantitatives, répétables |
US9968261B2 (en) | 2013-01-28 | 2018-05-15 | The General Hospital Corporation | Apparatus and method for providing diffuse spectroscopy co-registered with optical frequency domain imaging |
US10893806B2 (en) | 2013-01-29 | 2021-01-19 | The General Hospital Corporation | Apparatus, systems and methods for providing information regarding the aortic valve |
US11179028B2 (en) | 2013-02-01 | 2021-11-23 | The General Hospital Corporation | Objective lens arrangement for confocal endomicroscopy |
US10478072B2 (en) | 2013-03-15 | 2019-11-19 | The General Hospital Corporation | Methods and system for characterizing an object |
US9784681B2 (en) | 2013-05-13 | 2017-10-10 | The General Hospital Corporation | System and method for efficient detection of the phase and amplitude of a periodic modulation associated with self-interfering fluorescence |
US10117576B2 (en) | 2013-07-19 | 2018-11-06 | The General Hospital Corporation | System, method and computer accessible medium for determining eye motion by imaging retina and providing feedback for acquisition of signals from the retina |
US11452433B2 (en) | 2013-07-19 | 2022-09-27 | The General Hospital Corporation | Imaging apparatus and method which utilizes multidirectional field of view endoscopy |
US10058250B2 (en) | 2013-07-26 | 2018-08-28 | The General Hospital Corporation | System, apparatus and method for utilizing optical dispersion for fourier-domain optical coherence tomography |
US10169861B2 (en) | 2013-12-27 | 2019-01-01 | Fujifilm Corporation | Image processing apparatus, non-transitory computer readable medium, and image processing method |
US9733460B2 (en) | 2014-01-08 | 2017-08-15 | The General Hospital Corporation | Method and apparatus for microscopic imaging |
US10736494B2 (en) | 2014-01-31 | 2020-08-11 | The General Hospital Corporation | System and method for facilitating manual and/or automatic volumetric imaging with real-time tension or force feedback using a tethered imaging device |
US10228556B2 (en) | 2014-04-04 | 2019-03-12 | The General Hospital Corporation | Apparatus and method for controlling propagation and/or transmission of electromagnetic radiation in flexible waveguide(s) |
US10912462B2 (en) | 2014-07-25 | 2021-02-09 | The General Hospital Corporation | Apparatus, devices and methods for in vivo imaging and diagnosis |
CN115541578A (zh) * | 2022-09-28 | 2022-12-30 | 佐健(上海)生物医疗科技有限公司 | 一种高通量超分辨宫颈细胞病理切片快速扫描分析系统 |
CN115541578B (zh) * | 2022-09-28 | 2023-10-24 | 佐健(上海)生物医疗科技有限公司 | 一种高通量超分辨宫颈细胞病理切片快速扫描分析系统 |
Also Published As
Publication number | Publication date |
---|---|
AU6093400A (en) | 2001-01-30 |
EP1203343A4 (fr) | 2006-08-23 |
JP2003504627A (ja) | 2003-02-04 |
EP1203343A1 (fr) | 2002-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6546123B1 (en) | Automated detection of objects in a biological sample | |
WO2001004828A1 (fr) | Detection automatique d'objets dans un echantillon biologique | |
US7272252B2 (en) | Automated system for combining bright field and fluorescent microscopy | |
US7428325B2 (en) | Method and apparatus for automated image analysis of biological specimens | |
US7226788B2 (en) | Automated slide staining apparatus | |
US8712118B2 (en) | Automated measurement of concentration and/or amount in a biological sample | |
US20050037406A1 (en) | Methods and apparatus for analysis of a biological specimen | |
US6631203B2 (en) | Histological reconstruction and automated image analysis | |
EP1256087A1 (fr) | Procede et appareil destines a realiser une analyse d'image automatisee sur des echantillons biologiques | |
WO2001006446A1 (fr) | Procede automatise d'analyse d'image de proteine residuelle |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2000947299 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 2000947299 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000947299 Country of ref document: EP |